Publication Name	World Journal of Methodology
Manuscript ID	21488
Country	Poland

Received	2015-07-16 08:25
Peer-Review Started	2015-07-19 18:17
To Make the First Decision	2015-10-28 18:07
Return for Revision	2015-11-07 14:42
Revised	2015-11-13 04:22
Second Decision	2016-01-31 11:49
Accepted by Journal Editor-in-Chief	2016-01-31 19:08
Accepted by Executive Editor-in-Chief	2016-02-24 14:21
Articles in Press	2016-02-24 14:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-07 21:09
Publish the Manuscript Online	2016-03-18 09:50

ISSN	2222-0682 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician’s insight
Manuscript Source	Unsolicited Manuscript
All Author List	Andrzej M Bugaj
Funding Agency and Grant Number
Corresponding Author	Andrzej M Bugaj, PhD, College of Health, Beauty Care and Education, 3 Brzeźnicka Str., 60-133 Poznań, Poland. andrzej.marcin.bugaj@gmail.com
Key Words	Localised prostate cancer; Focal therapy; Vascular-targeted photochemotherapy; Methodology; Clinical trials
Core Tip	Vascular targeted photochemotherapy (VTP) represents new paradigm in focal therapy of prostate cancer (PCa). Physicochemical, pharmacodynamic and pharmacokinetic properties of padoporfin and pade-liporfin, which are palladium derivatives of bacte-riochlorin, make them suitable photosensitizers for VTP. Good visualisation of tumours and selective targeting of tumour lesion are mandatory for VTP to be efficient. Results of clinical trials confirm safety and efficiency of VTP in treatment of PCa. New protocols are necessary to make VTP standard method of PCa therapy.
Publish Date	2016-03-18 09:50
Citation	Bugaj AM. Vascular targeted photochemotherapy using pado­porfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician’s insight. World J Methodol 2016; 6(1): 65-76
URL	http://www.wjgnet.com/2222-0682/full/v6/i1/65.htm
DOI	http://dx.doi.org/10.5662/wjm.v6.i1.65

Full Article (PDF)	WJM-6-65.pdf
Full Article (Word)	WJM-6-65.doc
Manuscript File	21488-Review.doc
Answering Reviewers	21488-Answering reviewers.pdf
Audio Core Tip	21488-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21488-Conflict-of-interest statement.pdf
Copyright License Agreement	21488-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	21488-Language certificate.pdf
Peer-review Report	21488-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	21488-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	21488-Scientific misconduct check.pdf
Scientific Editor Work List	21488-Scientific editor work list.pdf